Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Continued Treatment Study for Adults with Advanced Cancer Using Pemigatinib
ItalyStudy on the Effectiveness of Olaparib and Bevacizumab for Maintenance Treatment in Patients with HRD-Positive Ovarian Cancer
ItalyStudy of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation
ItalyStudy on Cannabidiol for Reducing Seizures in Children and Young Adults with Severe Epilepsy Associated with Rare Diseases
ItalyStudy on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex
ItalyStudy on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients
ItalyStudy of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer
ItalyStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma
ItalyStudy on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B
ItalyStudy on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer
ItalyStudy on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer
ItalyEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
